Skip to main content
Log in

Role of mean platelet volume in triagging acute coronary syndromes

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Background: Acute coronary syndromes, characterized by the rupture of unstable plaque and the subsequent thrombotic process involving platelets, have been increasing in relative frequency. The central role of platelet activation has long been noticed in this pathophysiology; hence, many therapies have been directed against it. In this study, we have aimed to search prospectively the value of mean platelet volume (MPV), which is a simple and accurate measure of the functional status of platelets, in patients hospitalized with diagnosis of acute coronary syndromes (ACS). Materials and methods: A total of 216 consecutive patients (156 male, 60 female) hospitalized with the diagnosis of non-ST segment elevation (NSTE) ACS within the first 24 h of their chest pain were enrolled. One hundred and twenty patients, matched according to sex and age, with stable coronary heart disease (CHD) (85 male, 35 female) were enrolled as a control group. Patients were classified into two group: those with unstable angina (USAP, n = 105) and those with non-ST segment elevation myocardial infarction (NSTEMI, n = 111). Results: MPVs were 10.4 ± 0.6 fL, 10 ± 0.7 fL, 8.9 ± 0.7 fL consecutively for NSTEMI, USAP and stable CHD with significant differences. Patients with ischemic attacks in the first day of hospitalization accompanied by >0.05 mV ST segment shift had significantly higher MPV compared to those without such attacks (P = 0.001). Multivariable logistic regression analysis yielded that MPV (P = 0.016), platelet count (P < 0.001), and the presence of >0.05 mV ST segment depression at admission (P = 0.002) were independent predictors of development of NSTEMI in patients presenting with NSTE ACS. Conclusion: In patients presenting with NSTE ACS, higher MPV, though there are overlaps among subgroups, indicates not only more risk of having NSTEMI but also ischemic complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE 3rd, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC Jr (2002) American College of Cardiology; American Heart Association. Committee on the Management of Patients with Unstable Angina. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction–summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol. 40(7):1366–1374

    Google Scholar 

  2. Fitzgerald DJ, Roy L, Catella F, Fitzgerald A (1986) Platelet activation in unstable coronary disease. N Eng J Med 315:983–989

    Article  CAS  Google Scholar 

  3. Lewis HD Jr, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE 3rd, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study. N Engl J Med 309:396–403

    Article  PubMed  Google Scholar 

  4. Schulman SP, Goldschmidt-Clermont PJ, Topol EJ, Califf RM, Navetta FI, Willerson JT, Chandra NC, Guerci AD, Ferguson JJ, Harrington RA, Lincoff AM, Yakubov SJ, Bray PF, Bahr RD, Wolfe CL, Yock PG, Anderson HV, Nygaard TW, Mason SJ, Effron MB, Fatterpacker A, Raskin S, Smith J, Brashears L, Gottdiener P, du Mee C, Kitt MM, Gerstenblith G (1996) Effects of Integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial. Circulation 94:2083–2089

    PubMed  CAS  Google Scholar 

  5. Karpatkin S (1969) Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest 48:1083–1087

    Article  PubMed  CAS  Google Scholar 

  6. Martin JF, Bath PMW, Burr ML (1991) Influence of platelet size on outcome after myocardial infarction. Lancet 338:1409–1411

    Article  PubMed  CAS  Google Scholar 

  7. Davies MJ, Thomas A (1984) Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Engl J Med 310:1137–1140

    Article  PubMed  CAS  Google Scholar 

  8. Karpatkin S (1978) Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 51:307–316

    PubMed  CAS  Google Scholar 

  9. Levin J, Bessman JD (1983) The inverse relationship between platelet volume and platelet number. J Lab Clin Med 101:295–307

    PubMed  CAS  Google Scholar 

  10. Thompson CB, Jakubowski JA (1988) The pathophysiology and clinical relevance of platelet heterogeneity. Blood 72:1–8

    PubMed  CAS  Google Scholar 

  11. Martin JF (1990) Platelet heterogeneity in vascular disease. In: Martin JF, Trowbridge EA (eds) Platelet heterogeneity: biology and pathology. Springer-Verlag, London, pp 205–226

    Google Scholar 

  12. Karpatkin S, Strick N (1972) Heterogeneity of human platelets. V. Differences in glycolytic and related enzymes with possible relation to platelet age. J Clin Invest 51:1235–1243

    Article  PubMed  CAS  Google Scholar 

  13. Karpatkin S (1969) Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. J Clin Invest 48:1073–1082

    Article  PubMed  CAS  Google Scholar 

  14. Martin JF, Trowbridge EA, Salmon GL, Plumb J (1983) The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 32:443–460

    Article  PubMed  CAS  Google Scholar 

  15. Jakubowski JA, Thompson CB, Vaillancourt R, Valeri CR, Deykin D (1983) Arachidonic acid metabolism by platelets of differing size. Br J Haematol 53:503–511

    Article  PubMed  CAS  Google Scholar 

  16. Tschoepe D, Roesen P, Kaufmann L, Schauseil S, Kehrel B, Ostermann A, Gries FA (1990) Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest 20:166–170

    PubMed  CAS  Google Scholar 

  17. Giles H, Smith REA, Martin JF (1994) Platelet glycoprotein IIb–IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 24:69–72

    Article  PubMed  CAS  Google Scholar 

  18. Heath MF, Evans RJ, Poole AW, Hayes LJ, McEvoy RJ, Littler RM (1994) The effects of aspirin and paracetamol on the aggregation of equine blood platelets. J Vet Pharmacol Ther 17(5):374–378

    Article  PubMed  CAS  Google Scholar 

  19. Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR (1983) Platelet size as a determinant of platelet function. J Lab Clin Med 101:205–213

    PubMed  CAS  Google Scholar 

  20. Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR (1982) Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity and function. Br J Haematol 50:509–519

    Article  PubMed  CAS  Google Scholar 

  21. Kishk YT, Trowbridge EA, Martin JF (1985) Platelet volume subpopulations in acute myocardial infarction: an investigation of their homogeneity for smoking, infarct size and site. Clin Sci 68:419–425

    PubMed  CAS  Google Scholar 

  22. Pizzulli L, Yang A, Martin JF, Lüderitz B (1998) Changes in platelet size and count in unstable angina compared to stable angina or non cardiac chest pain. Eur Heart J 19:80–84

    Article  PubMed  CAS  Google Scholar 

  23. Thompson CB, Love DG, Quinn PG, Valeri CR (1983) Platelet size does not correlate with platelet age. Blood 62:487–494

    PubMed  CAS  Google Scholar 

  24. Martin JF, Penington DG (1983) The relationship between the age and density of circulating 51-Cr labelled platelets in the sub-human primate. Thromb Res 30:157–164

    Article  PubMed  CAS  Google Scholar 

  25. Yang A, Pizzulli L, Luderitz B (2006) Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 117(4):371–377

    Article  PubMed  CAS  Google Scholar 

  26. Alexander JH, Harrington RA, Tuttle RH, Berdan LG, Lincoff AM, Deckers JW, Simoons ML, Guerci A, Hochman JS, Wilcox RG, Kitt MM, Eisenberg PR, Califf RM, Topol EJ, Karsh K, Ruzyllo W, Stepinska J, Widimsky P, Boland JB, Armstrong PW (1999) Prior aspirin use predicts worse outcomes in patients with non-ST elevation acute coronary syndromes. Am J Cardiol 83:1147–1151

    Article  PubMed  CAS  Google Scholar 

  27. Parise LV, Venton DL, Le Breton GC (1982) Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP. J Pharmacol Exp Ther 222(1):276–281

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Birhan Yilmaz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yilmaz, M.B., Cihan, G., Guray, Y. et al. Role of mean platelet volume in triagging acute coronary syndromes. J Thromb Thrombolysis 26, 49–54 (2008). https://doi.org/10.1007/s11239-007-0078-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-007-0078-9

Keywords

Navigation